Table 2.

In vitro anti-proliferative effect of maslinic acid.

Origin	Cell Line	IC50 (μM)	References
Human colorectal adenocarcinoma	HT-29	101.2	[27]
	HT-29	61	[28]
	Caco-2	85	[28]
	Caco-2	15.4	[49]
Human hepatocellular carcinoma	HepG2	69.1	[49]
Human breast adenocarcinoma	MCF-7	136.0	[49]
Human salivary gland adenoid cystic carcinoma	ACC-2 (low metastasis)	43.7	[46]
	ACC-M (high metastasis)	45.8	[46]
Human transitional cell urinary bladder carcinoma	T24	33.0	[47]
	253J	71.8	[47]
	TCCSUP	28.0	[47]
Human transitional cell urinary bladder papilloma	RT4	42.7	[47]
Human synovial sarcoma	SW 982	45.3	[48]
Human uterus leiomyosarcoma	SK-UT-1	59.1	[48]